ANTIBIOTIC RESISTANCE PROFILE OF ISOLATED BACTERIA AT THE SANGMELIMA REFERENCE HOSPITAL, SOUTH CAMEROON REGION: A RETROSPECTIVE STUDY 

Jacky Njiki Bikoï1*image, Esther Del Florence Moni Ndedi1image, Mellissa Borisse Tsanga Manga1image,

Elsa Makue Nguiffo1image, Alexandra Emmanuelle Membangbi1image, Sharonne Ladiff Koko-Ta1image

Donatien Serge Mbaga1image, Chris André Mbongue Mikangue1image, Olivier Ndongo Bela1image

André Urbain Njiki Bikoi2image, Marie Michelle Eone3image, Sara Honorine Riwom Essama1

1Department of Microbiology, Faculty of Science, The University of Yaoundé I, Cameroon.

2Ntam Subdivisional Medical Centre, Kumba, Cameroon.

3Mbalmayo District Hospital, Mbalmayo, Cameroon.

ABSTRACT 

Background and objective: Bacterial resistance to antibiotics is now one of the most serious threats to global health. Knowledge of the main bacterial species responsible for bacteremia and their antibiotic resistance profile makes possible to provide an objective basis for effective antibiotic therapy. However, in the South Cameroon region, microbiological documentation is not always available. The objective of our study was to determine the resistance profile of bacteria isolated at the Sangmélima Reference Hospital.

Methods: It was a retroprospective study on biological samples collected from interned and ambulatory patients seen at the Sangmélima Reference Hospital during the period from January 2021 to October 2021.The samples were cultured on specific media and the susceptibility was carried out on agar media using Kirby-Bauertechnique and interpretation according to the 2020 CASFM Guidelines. 

Results: For the retrospective part, GNB were most represented (15/26; 57.7%,) with the E. coli (n=12/15) and only Staphylococcus spp for GPB (n=11/26). Staphylococcus resistance was particularly relevant with 81.81% to erythromycin, 63.63% to cefoxitin and 72.72% to Cotrimoxazole. E. coli showed a resistance of 66.66% for augmentin and 83.33% for cefuroxime. In the prospective part, GPB were only represented by Staphylococcus epidermidis (7/7 ; 50%), and GNB included E. coli (3/7 ; 21.42%), K. pneumoniae (2/7; 14.29%) and A baumannii (2/7; 14.29%). For all isolated bacteria strains, a high resistance to the majority of betalactams and penicillin was observed. However, bacteria with greater antibiotic resistance were Staphylococcus strains, highly resistant to beta-lactams, while A. baumannii strains showed higher resistance, and E. coli especially to penicillins and fluoroquinolones.

Conclusion: E. coli and Staphylococcus spp were predominant isolated bacteria with high rate of resistance to antibiotics frequently used in hospital. Strict adherence to infection prevention practices and judicious use of antibiotics are recommended to slow te spread of antimicrobial resistance (AMR).

Keywords: A. baumannii, Antibacterial resistance, E. coli, Staphylococcus spp., South Cameroon region.

 

INTRODUCTION

 

Bacterial infections are serious conditions, responsible for significant morbidity and mortality worldwide, and are among the most common care associated infections. In developing countries, Such infections remain currently a major public health problem1. Several studies conducted in Cameroon demonstrate the frequent involvement of Staphylo-coccus aureus in infections associated with a mortality of 15%-60%, a full resistance of Escherichia coli to amoxicillin and amoxicillin + clavulanic acid. Some lactose-fermenting coccobacilli such as A. baumannii and Pseudomonas aeruginosa show a recent increase in resistance to imipenem and piperacillin-tarzobactam2,3. Napa et al., demonstrated that P. aeruginosa strains circulating in the Center region have several enzymatic mechanisms of resistance to antibiotics associated with a high production of biofilm4. At the South Cameroon region, microbiological documenta-tion is not always present. We have therefore proposed to determine the the frequency of bacteria isolated within the Sangmélima Reference Hospital (HRS) and to evaluate their resistance to antibiotics in order to provide a database for future comparative studies, by analyzing hospital statistics over 6 months, in addition to a four-month bench job.

 

METHODS

 

Study design: It was a ten months period retro-prospective study carried out in the Microbiology Laboratory of the Sangmélima Reference Hospital (HRS), Sangmélima being a forest town located in the Southern Region of Cameroon, and knowing that hospital attendance has declined significantly during this covid-19 period. The retrospective part (January to June 2021) was carried out from the registers and antibiograms of the archives of the HRS Microbiology Laboratory. The prospective part was a 4-month bench work (July to October 2021) performed on clinical samples. All isolates came from diagnostic samples of patients hospitalized in the various HRS departments, ambulatory patients and samples from other health facilities in the region. Ethical clearance was obtained from The Yaoundé 1 University Institutional Ethics Committee, authorization to collect samples from HRS, and informed consent from all the study participants. Specimens were collected from both in and out patients as described by Rémic5.

Retrospective part data collection : It consisted in extracting the results of the tests and antibiograms carried out from January to June 2021, from the bench registers of the Laboratory. The variables collected were: (a). Frequency of examinations requested, (b). Distribution by service, (c). Sex, (d). Sample type, (e). Isolated germs, (f). Antibiotic susceptibility. 

Prospective part samples: Some samples were taken from the laboratory, others from the various departments of the hospital, and some sent from other health facilities in the southern region. These included urine and blood samples, pus and vaginal swabs, puncture fluids and semen.

Isolation and identification:Depending on the type of sample, a macroscopic examination was first carried out, then a stocking done by exhaustion on Chapman agar medium, chocolate +VCN and fresh blood agar, on EMB, CLED agar, Sabouraud agar, Columbia blood agar, Cooked blood agar + VCN. Each culture was followed by incubation from 18 to 24 hours incubation at 37°C. Colonies from positive primary cultures were stained using the Gram staining method. From the obtained results (Gram-negative bacteria-GNB bacteria and Gram-positive bacteria- GPB) biochemical tests were carried out using oxidase test, Catalase test, Coagulase test and DNase test. Identification of bacterial strian was made by API 20 NE (BioMérieux, France), following the manufacturer's instructions.

Antibiotic sensitivity test:The susceptibility test was performed using the Kirby Bauer disk diffusion method according to the Clinical and Laboratory Standards Institute (CLSI) guidelines. The bacterial inoculum was obtained by using isolated colonies on nutrient agar and homogenized in 5ml of sterile distilled water. This suspension was then adjusted in comparison to the McFarland 0.5 standard. The test was carried out in series of three copies according to the CLSI protocol M2-A97. The antibacterial susceptibility of GPB and NGB was determined using the antibiotic discs listed below. Inhibition diameters measurement and interpretation (sensitive, intermediate, resistant) were made according to CASFM V1.2 20206. BGPs were tested for Amoxicillin, Oxacillin, Cefoxitin, Cefota-xime, Chloramphenicol, Gentamicin, Erythromycin, Clindamycin, Norfloxacin, Fusidic acid, Cotrimox-azole, Rifampicin, Ciprofloxacin, Levofloxacin, Vanc-omycin, Kanamycin, Tobramycin, Netilmicin, Tetracy-cline, Minocycline, Tigecycline, Fosfomycin, Novob-iocin. NGBs were tested for Amoxicillin, Augmentin, Piperacilline,  Ticarcilline+Clavulanic sterile acidev-illon, Cefoxitine, Cefotaxime, Cefuroxime, Ceftazi-dime, Cefepime, Cefixime, Imipenem, Amikacine, Gentamicin, Aztreonam, Nalidic acid, Levofloxacin, Ciprofloxacin, Fosfomycin, Cotrimoxazole, Colistine, Tobramycin, Tetracycline, Netilmycin, Ertapenema.

Detection of extended-spectrum beta lactamases: Extended-spectrum beta lactamases (ESBLs) are enzymes found in certain bacteria and are responsible for their resistance to antibiotics such as penicillins and cephalosporins. The double disc synergy was used to screen all the isolates for ESBLs production as recommended by CASFM6. Amoxicillin + clavulanic acid disc (30 µg/10 µg) was placed in the centre, equidistant from the ceftazidime disc (30 µg,) cefamin (30 µg) and cefotaxime (30 µg). A strain was ESBL positive if the production of inhibition zones in the form of champagne cork was observed between the amoxicillin + clavulanic acid discs and the ceftazidime, cefadepima, cefotaxime discs. Otherwise, the strain was negative ESBL.

Statistical analysis: Data was entered on Microsoft Excel 2016.  Data analysis was performed with IBM SPSS Statistics Version 22.0. The descriptive data are presented in terms of frequency and percentages.

Ethical considerations: The study was performed after receiving an ethical clearance from the Joint Institutional Board for Animals and Human Bioethics (JIRB) of the University of Yaoundé 1 (Ref N° BTC-JIRB2022-019) and an approval from the Ethics Committee the approval of the Reference Hospital of Sangmelima(N°01/021/ARM/MINSANTE/SG/HRS/ CM du 21 Juillet 2021). 

 

RESULTS

 

Retrospective epidemiological profile of samples : From the bench records of the laboratory the epidemiological profile of samples with identified bacteria could be established (Table 1). We recorded many samples, including urine (n=13; 50%), vaginal swabs (n=7; 26.92%), stool (n=3; 11.54%) and urethral secretions (n=2 ; 7.69%) were the most represented. 

Samples from outpatients were the least represented (n=7; 26.92%) compared to 73.08% of inpatients (n= 19) shared majoritary between medical and emergency departments (15.38% and 23.07% respecti-vely).

Total 15 samples were recorded (57.7%) from women and 11 samples (42.30%) from men. The sample most represented in both males(n=7) and females (n=5) was urine, followed by stool. Gram-negative bacilli were most represented (n=15 ; 57.7%,) with the E. coli(n=12) and only Staphylococcus spp for Gram-positive bacilli (n=11). E. coli was the most isolated germ in the samples and was mainly present in urine and vaginal secretions. Staphylococcus spp strains were mostly isolated from urine and urethral secretions. Staphylococcus resistance was particularly relevant with 81.81% to erythromycin, 63.63% to cefoxitin and 72.72% to Cotrimoxazole. E. coli showed a resistance of 66.66% for augmentin and 83.33% for cefuroxime. 

Prospective epidemiological profile of samples: In four months, fourteen participants were recruited for this study part, 12 men for 2 women, according to inclusion criteria. The average age of the sample donors was 29 years, ranging from 6 days to 78 years. Various samples were collected, the majority of which were urethral secre-tions and urine (n=4 ; 28.57% each) and at lower frequencies blood (n=1; 7.14%).

The samples were from both hospital outpatients (50%, n=7) and in-patients (50%, n=7). For interned patients, the pediatrics department was in the lead with (n=4; 57.14%) of samples provided followed by the surgery department (n=2 ; 28.57%) (Table 2). 

Four bacterial species were isolated and identified. Half belonged to the Gram-positive coccis group represented by S. epidermidis (n=7; 50%), the other half belonged to the Gram-negative bacilli group and included E. coli species isolated at a frequency of (n=3; 21.42%), closely followed by K. pneumoniae (n=2; 14.29%) and A. baumannii (n=2; 14.29%), as shown in Table 3.  Men were the most infected, mostly by S. epidermidis (58.33%, n=7/12). In women, however, E. coli was the most isolated species, at the same frequency as A. baumannii.

S. epidermidis was the bacterial species most isolated from urethral secretions (100%), pus (100%). E. coli was isolated more frequently in vaginal secretions and urine at frequencies of 100% (n=2), 50% (n=2) respectively.

Antibiotic sensitivity test : E. coli strains resistance to penicillins remains very high, 100% for amoxicillin and augmentin. The same is true for fluoroquinolones, particularly levofloxacin and ciprofloxacin, were innefficacious with 100% resistance each (Figure 1). All isolated strains of A. baumanii were resistant to all ß-lactam (100%) except ertapenem (Figure 2). Isolated K. pneumoniae strains were resistant to penicillins (100%) and fosfomycin (100%) (Figure 3). For S. epidermidis, many resistances were observed against all antibiotics classes and higher for ß-lactam (with a  resistance of 71.42% to cefoxitin), and tigecyclin (100%) (Figure 4).

 

DISCUSSION

 

For the retrospective fraction, GNB was more represented (57.7%) with the highest isolation frequency for Escherichia coli, followed by Salmonella spp and Klebsiella spp. and with GPB, only Staphylococcus spp. was isolated. These results, despite used small sample size, confirm the findings of Raed et al., in Jordan reported isolation frequencies of 29%, 14%, 7% and 3.5%, respectively, for E. coli, K. pneumoniae, S. enterica, and S. epidermidis8.The frequency difference observed is due to the nature of the sample. Indeed, germs such as E. coli are usually isolated at lower frequencies in wounds than in urine or genital secretions as in current study. Staphylococcus  resistance was particularly relevant with 81.81% to erythromycin, 63.63% to cefoxitin and 72.72% to cotrimoxazole. E. coli showed a resistance of 66.66% for augmentin and 83.33% for cefuroxime. These results are in agreement with the reports from Cameroon2 and other African countries, as was the case in Ethiopia in 2017 where Mulu et al., revealed GPB and GNB resistance to cotrimoxazole and penicillin9. Indeed, these antibiotic families are widely prescribed in the first intension and HRS being a reference structure in the Southern Region, patients often come from other health structures where probabilistic treatments based on the use of these molecules have sometimes already been initiated. S. epidermidis (50%), as well as E. coli (21.42%), closely followed by K. pneumoniae and A. baumannii were successfully isolated and identified in this study. These trends are similar to previous works elsewhere in Cameroon by Ateudjeu et al., for who E. coli had a sample high prevalence while it was in stool, Kousseri city (Far North region)3, Mbamyah et al., who revealed K. pneumoniae as the most prevalent species isolated from Klebsiella isolates identifiedin Yaoundé (Central Region)10, and Okalla et al., who showed low rates of A. baumannii(3.8%) from clinical specimens in the city of Douala (Littoral region)11.This can be a proof that these strains are circulating in Cameroon.

For all isolated bacteria strains, a high resistance to the majority of beta lactams and penicillin was observed. However, bacteria with greater antibiotic resistance were Staphylococcus strains, highly resistant to beta-lactams, while A. baumannii strains showed higher resistance, and E. coli especially to penicillins and fluoroquinolones. This overall high rate of resistance of the isolates to the penicillins could be explained by the over use of these drugs in the treatment of common infections and ease of drug acquisition without prescription and even from road side vendors10. A High resistance to colistin was noted in our study, which complicates treatment because colistin is recommended for the treatment of A. baumannii infections12.

Limitations

It was a monocentric study, done in Sangmélima a forest town located in the Southern Region of Cameroon, and knowing that hospital attendance has declined significantly during this covid-19 period. A small sample size of the study. 

 

ACKNOWLEDGMENTS 

 

We sincerely thank the Sangmelima Reference Hospital staff which permits us to recruit patients, the Medical Biology Laboratory of the Mbalmayo District Hospital and the Microbiology laboratory in Faculty of Science of University of Yaoundé I for providing necessary material, equipments and facilities to carry out the research.

 

CONFLICT OF INTEREST

 

The authors have declared that there is no conflict of interest associated with this work.

 

AUTHOR'S CONTRIBUTION

 

Protocol design was done by J Njiki Bikoï, EDF Moni Ndedi, SH Riwom Essama, MB Tsanga Manga. Data collection tools development was done by MB Tsanga Manga, MM Eone, AU Njiki Bikoi, SL Koko-Ta, E Makue Nguiffo, AE Membangbi, O Ndongo Bela, DS Mbaga. Supervision of data collection was done by J Njiki Bikoï, EDF Moni Ndedi, SH Riwom Essama. Data collection, analysis and interpretation was done by MB Tsanga Manga, MM Eone, SL Koko-Ta, E Makue Nguiffo, AE Membangbi, DS Mbaga, CAMbongue Minkangue. 

 

REFERENCES 

 

  1. Agyepong N, Govinden U, Owusu-Ofori A, Essack SY. Multidrug-resistant gram-negative bacterial infections in a teaching hospital in Ghana. Antimicro Resist Inf Cont 2018; 7:37. https://doi.org/10.1186/s13756-018-0324-2
  2. Kengne M, Fotsing O, Ndomgue T, Nwobegahay MJ. Antibiotic susceptibility patterns of Staphylococcus aureusstrains isolated at the Yaounde Central Hospital, Cameroon: A retro prospective study. Pan African Medical Journal 2019; 32:103.http://dx.doi.org/10.11604/pamj.2019.32.103.15743 
  1. Ateudjieu J, Beyala BL, Guenou E, Chebe NA, Chukuwchindun AB, Koukoum GAP, Bisseck ZAC. Profile and antibiotic susceptibility pattern of bacterial pathogens associated with diarrheas in patients presenting at the Kousseri Regional Hospital Annex, Far North, Cameroon. Pan African Med J 2018; 29:170.http://dx.doi.org/10.11604/pamj.2018.29.170.14296 
  1. Napa Tchuedji YLG, Gonsu Kamga H, Lyonga Mbamyah E, Chafa Betbeui A, Assana IR, Fonyuy Bongnyang G, Guenou E and Etoa FX. Study of resistance mechanisms and evaluation of biofilm detection tests in clinical isolates of Pseudomonas aeruginosa circulating in Yaounde, Cameroon. Acta Scientific Microbiol 2021; 4(12): 104-110.http://dx.doi.org/10.31080/ASMI.2021.04.0973 
  1. Repository in medical microbiology. 4th edition. 2010.
  2. CA-SFM: Antibiogram Committee of the French Society of Microbiology 2020.   (accessed 17 April 2022).
  3. CLSI (Clinical Laboratory Standards Institute). Performance Standards for Antimicrobial Disc Susceptibility Tests. (11th), Approved standard M02-A11– Publication of Clinical and Laboratory Standards Institute [CLSI), 2012, USA, 32.
  4. Ennab R, Al-Momani W, Al-Titi R, Elayan A. Antibiotic profile of pathogenic bacteria isolated from postsurgical site infections in public hospitals in Northern Jordan. Infect Drug Resist 2022; 15:359-366.https://doi.org/10.2147/IDR.S350406 
  5. Mulu W, Abera B, Yimer M, Hailu T, Ayele H, Abate D. Bacterial agents and antibiotic resistance profiles of infections from different sites that occurred among patients at Debre Markos Referral Hospital, Ethiopia: A cross-sectional study. BMC Research Notes 2017; 10, 254.https://doi.org/10.1186/s13104-017-2584-y
  6. Mbamyah E, Enyeji F, Torimiro J, Mangum P, Djuissi M, Teukam A, Mesembe M, Ikomey G, Betbeui A, Sedena D, Baiye W, Eyoh A and Gonsu H. High prevalence of multidrug resistant Klebsiellaspecies isolated from the Yaounde University Teaching Hospital, Cameroon. Open J Med Micro 2021; 11, 91-99.http://dx.doi.org/10.4236/ojmm.2021.112008 
  7. Okalla Ebongue C, Mengue RE, Nda Mefo’o JP, Dongmo Tsiazok M, N’guessan Kouassi R, Ngo Bum E. Antimicrobial multi-resistance of Acinetobacter baumanii isolated from clinical specimens in Douala (Cameroon). J Dis Med Plants 2015; 1(2):31-36.http://dx.doi.org/10.11648/j.jdmp.20150102.12 
  8. Katip W, Meechoui M, Thawornwittayakom P, Chinwong D, Oberdorfer P. Efficacy and safety of high loading dose of colistin in multidrug-resistant Acinetobacter baumannii: A prospective cohort study. J Intensive Care Med 2019; 34(11-12):996-1002.http://dx.doi.org/10.1177/0885066617725694